BrightGene plans to list in Hong Kong
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, BrightGene announced that the company plans to issue H shares and list on the Main Board of the Hong Kong Stock Exchange. The company will fully consider the interests of existing shareholders and the conditions of domestic and foreign capital markets, and will choose an appropriate timing and issuance window to complete this issuance and listing within the validity period of the shareholders' meeting (i.e., 24 months from the date of approval by the company's shareholders' meeting or other agreed extended periods)
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments